Report

An agreement with UGAP

An agreement with UGAP

SIGNIFICANT NEWS

FACT

DMS announced that it has been selected as a supplier to UGAP – a French public purchasing body – for its Platinum and Optima DRF solutions.


ANALYSIS

Again, the group puts forward a release that looks positive news. According to management, the agreement signed with UGAP (to be carried out through NGI’s salesforce) could bring as much as €10m in sales for DMS over four years. Why not. That said, a number of past releases have mentioned or understated big numbers could be reached (including the agreement with NGI in January 2017 or that with UniHA signed in early 2018) with no tangible results so far. Moreover, there is no commitment for UGAP to buy anything as we understand the agreement. The figure put forward is only DMS’s estimate of what the agreement could bring. The other issue is of course the pricing of such agreements (by definition such bodies tend to put pressure on prices) and the fact NGI will take its margins a well. In short, it remains to be seen if/when volumes go up thanks to this new agreement and, secondly, the kind of margins DMS is able to achieve. Investors will be happy to wait, we believe, and this all the more since the group’s credibility has been damaged as of late.


IMPACT

We will not change our forecasts, since future sales linked to this agreement are very theoretical so far.
Underlying
Diagnostic Medical Systems

DIAGNOSTIC MEDICAL SYSTEMS SA, (formerly known as DMS), is a France-based company, which together with its subsidiaries, designs, produces and markets medical imagery devices dedicated to conventional and digital radiology as well as bone densitometry. The Company manufactures a range of products for bone densitometry examination, including the ultrasound imaging system UBIS 5000, Challenger Envision, Stratos dR and Stratos. In the radiology sector, its products include Baccara dRF 43, EOL, Platinum and Da Vinci solutions, among others. In addition, it offers such products as scanners, transcranial Doppler, and Giotto Image mammography system. The Company operates several direct subsidiaries, AXS Medical, Apelem SAS, which manufactures radiology equipment, Medilink SARL, which produces Doppler and bone densitometry devices, Apelem SA, based in Spain, Alpha MOS based in France and one indirect subsidiary, SA Apelem and one indirect affiliated company, Spectrap.

Provider
AlphaValue Corporate Services
AlphaValue Corporate Services

AlphaValue Corporate Services capitalise on the research and credit analysis expertise deployed by AlphaValue with major institutional investors at European level over the past nine years. The proprietary tools and processes enabling AlphaValue Corporate Services to establish a valuation and/or a credit risk assessment are identical to those used by AlphaValue to the benefit of its institutional clients. The only difference is the recognition that a company evaluation cannot be dissociated from the fact that the latter is paying for the service (AlphaValue Corporate Services), as opposed to the investor footing the bill (AlphaValue). AlphaValue’s research tools are characterised by the transparency of the valuation methodologies, their responsiveness to market data and by nine years’ experience of a universe numbering more than 450 European companies. Through its coverage and sector exhaustiveness, AlphaValue ranks alongside the major research houses in Europe and constitutes the only new entrant to the European space in the past decade. This significant presence is reflected in an unrivalled distribution capability via platforms commonly adopted by investors to access research: Factset, Bloomberg, Capital IQ and the numerous websites. AlphaValue is one the largest research contributors to these platforms, to the benefit of AlphaValue Corporate Services issuer clients.  The AlphaValue Corporate Services analysts are AlphaValue’s sector specialists. Their robust knowledge of the business models in their sectors enables the rapid generation of incisive, relevant research and advantageous interaction with the management teams.

Analysts
Fabrice Farigoule

Other Reports on these Companies
Other Reports from AlphaValue Corporate Services

ResearchPool Subscriptions

Get the most out of your insights

Get in touch